JPMorgan Chase Financial Co. LLC has filed a pricing supplement for $6.14 million in structured investments known as Buffered Callable Range Accrual Notes. This filing, dated October 29, 2026, is significant as it highlights the company's ongoing efforts to expand its offerings in the national commercial banking sector.
The notes are linked to the S&P 500 index and are fully guaranteed by JPMorgan Chase & Co. They are designed for investors who believe that the index will remain above a certain threshold, providing periodic interest payments at a rate of 7.20% per annum, contingent on market performance.
Background
JPMorgan Chase Financial Co. LLC, classified under the SIC code 6021 for National Commercial Banks, operates as a subsidiary of JPMorgan Chase & Co. The company is incorporated in Delaware and has its business address at 383 Madison Avenue, New York, NY. The firm has been active in filing various forms with the SEC, including multiple recent filings of the 424B2 type on October 29, 2026.
What the Filing Says
The pricing supplement outlines that the notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial, guaranteed by JPMorgan Chase & Co. The notes are set to mature on October 31, 2031, and are subject to certain conditions regarding interest payments and principal repayment.
The notes are designed for investors who believe that the Closing Level of the S&P 500 Index will remain at or above the Minimum Index Level of 85.00% of the Initial Value on each Accrual Determination Date.
Impact
This filing may affect a range of stakeholders, including investors looking for structured investment opportunities and competitors in the national commercial banking sector. The potential for periodic interest payments linked to a major index may attract investors seeking alternative investment strategies.
What's Next
The filing does not specify what happens next. However, the notes are expected to settle on or about October 30, 2026, and further developments may follow as the company continues to engage with investors.
Read Next
Mirum Pharmaceuticals reports stock sale by former officer
Basswood Financial Fund sells shares of Regional Management Corp.
Basswood Financial Fund Files to Sell Shares in Regional Management
HCA Healthcare Officer Jon M. Foster Files to Sell Shares
Regional Management Corp. Sees Shareholder Stock Sale
Wampler Kira Scherer Reports Stock Transactions for Doximity









